YLYuanyuan Liu

Yuanyuan Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yuanyuan Liu has a total of 58 co-authors. Here are the top co-authors by number of shared publications:

  • Xiang Liu

    Department of Health Behavior and Social Medicine, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China

    10 shared publications
  • Xianmei Yang

    Psychiatric Department, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China

    6 shared publications
  • Hu Xiang

    Sichuan Mental Health Center, The Third People's Hospital of Mianyang, Mianyang, Sichuan, China

    5 shared publications
  • Jun Liu

    Psychiatric Department, The Third Hospital of Mianyang, Sichuan Mental Health Center, Mianyang, China

    5 shared publications
  • Ruoxin Fan

    Sichuan Mental Health Center, The Third People's Hospital of Mianyang, Mianyang, Sichuan, China

    5 shared publications
  • Dan Wang

    Sichuan Mental Health Center, Third Hospital of Mianyang, Mianyang, China

    4 shared publications

Latest Publications

  • Open Access

    An exploratory study on the impact of medication usage patterns on relapse among community schizophrenia patients

    by Lan Wu, Xuanyi Hu, Xiang Liu, Yuanyuan Liu, Xiangrui Wu

    Relapse is highly prevalent among individuals with schizophrenia, imposing a significant burden on public health systems and patients. Medication usage pat

  • Open Access

    Association of ambient temperature with mortality in community-based patients with severe mental disorders: a time-stratified case-crossover study in western China

    by Bo Yi, Chuanlong Zuo, Sheng Chen, Xianmei Yang, Jun Liu, Xing Zhao, Ruoxin Fan, Yuanyuan Liu, Xiang Liu

    Previous studies have indicated that high temperatures are associated with excess mortality among individuals with mental disorders, but comprehensive eval

  • Open Access

    Association between social support and quality of life in community-dwelling schizophrenics: the mediating roles of anxiety and depression symptoms

    by Yue Chen, Xuanyi Hu, Chaoxinyu Xiong, Yi Guo, Luyi Wei, Xiaoyan Wan, Qin Yang, Changjiu He, Yuanyuan Liu, Xiang Liu

    The quality of life of schizophrenics is an important public health issue, but studies exploring the mechanisms that contribute to the quality of life are

    • 28 June 2025
      • Vol. 50  (6) , 1042-1051
    Open Access

    [Association between stigma and quality of life in community-dwelling patients with schizophrenia: Multiple mediating roles of anxiety and depression symptoms].

    by Yue Chen, Xiaoyan Wan, Qin Yang, Changjiu He, Xuanyi Hu, Xiang Liu, Yuanyuan Liu

    Stigma is common among community-dwelling patients with schizophrenia and has a profound negative impact on both psychiatric symptoms and quality of life. This study aims to explore the association between stigma and quality of life in this population and to examine the multiple mediating roles of anxiety and depression symptoms. The multi-stage stratified cluster random sampling method was used to select the community-dwelling patients with schizophrenics in Chengdu, Sichuan Province, China. The questionnaire included general demographic characteristics, stigma question, the Generalized Anxiety Disorder-7 (GAD-7) scale, the Patient Health Questionnaire-9 (PHQ-9), and the 12-item Short Form Health Survey (SF-12). The SF-12 was used to measure quality of life, including physical health and mental health dimensions. A multiple mediation model was used to analyse the mediating effects of anxiety and depression symptoms together between stigma and quality of life. A total of 1 087 community patients with schizophrenia were included with a mean age of 50.68±12.73 years; 525 (48.30%) were male. Stigma was reported by 543 patients (49.95%). Anxiety symptoms were present in 292 patients (26.86%), and depression symptoms in 407 patients (37.44%). The physical health quality of life score was 72.01 ± 20.99, and the mental health quality of life score was 71.68 ± 19.38. Multiple mediation analysis showed that stigma directly affected quality of life, and also indirectly affected quality of life through anxiety and depression symptoms. Anxiety and depression jointly mediated 42.26% of the total effect of stigma on physical health quality of life and 47.51% on mental health quality of life. Reducing stigma and preventing anxiety and depression symptoms in community-dwelling patients with schizophrenia can effectively improve their quality of life and support reintegration into society.

  • The association between medication adherence and the risk of different violent behaviors: A cohort study in young patients with severe mental illness

    by Xiaolan Yin, Chuanlong Zuo, Ruoxin Fan, Jun Liu, Hu Xiang, Mingjin Huang, Xing Zhao, Xiang Liu, Xianmei Yang, Yuanyuan Liu

  • Mediation role of gut microbiota in the association between ambient fine particulate matter components and cardiovascular disease: Evidence from a China cohort

    by Shaokun Yang, Rui Yu, Fen Yang, Jiawei Li, Lele Wang, Gonghua Wu, Liling Chen, Tingting Yang, Zhuoma Duoji, Yanjiao Wang, et al.


  • Open Access

    Medication non-adherence and self-inflicted violence behaviors among 185,800 patients with schizophrenia in the community: a 12-year cohort study

    by Chuanlong Zuo, Xianmei Yang, Xiangrui Wu, Ruoxin Fan, Jun Liu, Hu Xiang, Yang Li, Xing Zhao, Xiang Liu, Yuanyuan Liu

    Background: Despite the importance of medication adherence in treatment effectiveness, little is known about the association between medication non-adherence and self-inflicted violence behaviors. We aimed to assess whether medication non-adherence increased the risk of self-inflicted violence behaviors among schizophrenics in communities (hypothesis 1) and whether the dose–response relationship existed (hypothesis 2). Methods: This 12-year cohort study in western China recruited 292,667 community-dwelling schizophrenics. The proportion of regular medication (PRM) was calculated by dividing the time of “regular adherence” by the total time of antipsychotic treatment during follow-up period as an indicator of medication adherence. For hypothesis 1, medication adherence was designated as a binary variable with a threshold of 0.8 (PRM); for hypothesis 2, medication adherence was specified as five-category and continuous variables, respectively. Inverse probability weighting and mixed effects Cox proportional hazards models were conducted for confounders control and survival analyses. Results: One hundred eighty-five thousand eight hundred participants were eligible for the final analyses, with a mean age of 47.49 years (SD 14.55 years), of whom 53.6% were female. For hypothesis 1, the medication non-adherence group (PRM < 0.8) had a lower risk of suicide (HR, 0.527, 95% CI, 0.447–0.620), an increased risk of NSSI (HR, 1.229, 95% CI, 1.088–1.388), and non-significant risk of attempted suicide compared with adherence group (PRM ≥ 0.8). For hypothesis 2, the lowest medication adherence (PRM < 0.2) was associated with increased risks of suicide attempt (HR, 1.614, 95% CI, 1.412–1.845), NSSI (HR, 1.873, 95% CI, 1.649–2.126), and a decreased risk of suicide (HR, 0.593, 95% CI, 0.490–0.719). The other non-adherence groups had lower risks for all three self-inflicted violence behaviors. The associations between medication adherence in continuous-variable and three outcomes were consistent with the categorical medication adherence results. Conclusions: Almost no medication taken as prescribed was associated with an increased risk of suicide attempt and NSSI. However, medication adherence did not appear to prevent completed suicide. Besides, patients with moderate adherence had a lower incidence of suicide attempt and NSSI. These findings highlight the need for a more detailed portrayal of medication adherence and the need to be vigilant for suicide intent in schizophrenics with good medication adherence who may be overlooked previously.


  • Open Access

    Medication Nonadherence and Risk of Violence to Others Among Patients With Schizophrenia in Western China

    by Yang Li, Hong Wen, Chaoxinyu Xiong, Chunying Lin, Xianmei Yang, Dan Wang, Ruoxing Fan, Jun Liu, Xing Zhao, Yuanyuan Liu, et al.

    Importance: Reducing violence to others in community-based patients with schizophrenia has important implications for public health. Increasing medication adherence is often used to reduce the risk of violence, yet little is known about the association between medication nonadherence and violence to others in this population.Objective: To examine the association between medication nonadherence and violence to others among community-based patients with schizophrenia.Design, Setting, and Participants: This large, naturalistic, prospective cohort study was performed in western China from May 1, 2006, to December 31, 2018. The data set was from the integrated management information platform for severe mental disorders. As of December 31, 2018, 292 667 patients with schizophrenia were registered in the platform. During follow-up, patients could enter or leave the cohort at any time. Maximum follow-up was 12.8 years, with a mean (SD) of 4.2 (2.3) years. Data analysis was conducted from July 1, 2021, to September 30, 2022.Exposures: Medication nonadherence.Main Outcomes and Measures: Violence to others throughout the follow-up period was the outcome, including minor nuisances, violating the Law of the People’s Republic of China on Penalties for Administration of Public Security (APS law), and violating criminal law. Information about these behaviors was provided by the public security department. Directed acyclic graphs were used to identify and control confounders. Propensity score matching and generalized linear mixed-effects models were used for analysis.Results: The final study sample included 207 569 patients with schizophrenia. The mean (SD) age was 51.3 (14.5) years, and 107 271 (51.7%) were women; 27 698 (13.3%) perpetrated violence to others, including 22 312 of 142 394 with medication nonadherence (15.7%) and 5386 of 65 175 with adherence (8.3%). In 112 710 propensity score–matched cases, risks of minor nuisances (odds ratio [OR], 1.82 [95% CI, 1.75-1.90]; P < .001), violating APS law (OR, 1.91 [95% CI, 1.78-2.05]; P < .001), and violating criminal law (OR, 1.50 [95% CI, 1.33-1.71]; P < .001) were higher in patients with nonadherence. However, the risk did not increase with higher medication nonadherence. There were differences in risk of violating APS law between urban and rural areas.Conclusions and Relevance: Medication nonadherence was associated with a higher risk of violence to others among community-based patients with schizophrenia, but the risk did not increase as medication nonadherence increased.


  • 精神分裂症患者生活质量及其影响因素

    by Chunying Lin, Xiaoyan Wan, Ruohan Zhang, Xianmei Yang, Yuanyuan Liu

    精神分裂症是一种复杂的慢性精神疾病。随着医学模式的转变,生活质量逐渐成为精神分裂症患者重要的预后指标。精神分裂症患者的生活质量水平低于一般人群和其他慢性病患者,年龄、性别、就业、文化程度、收入、居住情况等社会人口学因素,精神症状、共病躯体疾病、服药依从性、洞察力等临床因素和社会支持、认知、病耻感、自尊和需求等社会心理因素是影响精神分裂症患者生活质量的主要因素,可通过药物和社会技能训练、家庭干预、认知矫正和认知行为治疗等心理干预措施以及社区综合干预来改善其生活质量。探索精神分裂症患者生活质量的影响因素及其改善措施,有助于提高患者生活质量水平。


  • Risk factors for mortality due to natural causes and suicide among people with severe mental illness in western China

    by Xiang Liu, Xianmei Yang, Dan Wang, Ruoxin Fan, Rongke Wang, Hu Xiang, Jun Liu, Yuanyuan Liu